CIK 0001851484
- Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 994362660
- Phone
- +1 908-967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Webb Carol Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-09-19 | Webb Carol Director | Grant or award | +300,000 | 300,000 | ||
| 2025-09-19 | Webb Carol Director | Grant or award | +300,000 | 300,000 | ||
| 2025-09-19 | Webb Carol Director | Grant or award | +300,000 | 300,000 | ||
| 2024-12-12 | Webb Carol Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-08-12 | Webb Carol Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 1 of 1 · 6 trades